Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 6-13 October 2015
v.31 no.4 BC Cancer Agency KEL Library Journals | Available | ||
BC Cancer Agency KEL Library Journals | Available | ||
v.31 no.2 BC Cancer Agency KEL Library Journals | Available | ||
v.31 no.3 BC Cancer Agency KEL Library Journals | Available |
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions; Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions; Guidelines on the use of intravenous immune globulin for hematologic conditions; Guidelines…
c.1 BC Cancer Agency VIC Library | Available |